Perrigo (PRGO)
(Delayed Data from NYSE)
$26.94 USD
-0.06 (-0.22%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $26.94 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
Brokerage Reports
Perrigo Company plc [PRGO]
Reports for Purchase
Showing records 341 - 360 ( 365 total )
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Ahead of 4Q12 - Hard To See Upside, But Momentum In Generics Makes It Even Harder to Bet Against.
Provider: CLAL FINANCE
Analyst: KREIZMAN J
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Weak Flu Season Dampens OTC Sales--Looking Forward to Easy Comparisons in FY13
Provider: CARIS & COMPANY
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Mucinex ORx Launch and JNJ OTC Delays Support Improving CHC Sales
Provider: AURIGA USA
Analyst: CHEN L
Company: Perrigo Company plc
Industry: Medical - Products
Initiating with Buy and $125 Price Target
Provider: AURIGA USA
Company: Perrigo Company plc
Industry: Medical - Products
Getting Potentially Closer to Rx-to-OTC Switches of Some Major Drug Categories--Lipitor Could Come Soon
Provider: CARIS & COMPANY
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
New Products to Drive Sales Growth Acceleration in 2H12--No Change to EPS Estimates
Provider: CARIS & COMPANY